March 28, 2020 23:00 UTC
DOYU ALERT, ROSEN, GLOBAL INVESTOR COUNSEL, Reminds DouYu International Holdings Limited Investors of Important Deadline in First Filed Federal Securities Class Action Lawsuit – DOYU
DOYU ALERT, ROSEN, GLOBAL INVESTOR COUNSEL, Reminds DouYu International Holdings Limited Investors of Important Deadline in First Filed Federal Securities Class Action Lawsuit – DOYU March 28, 2020 23:00 UTC DOYU ALERT, ROSEN, GLOBAL INVESTOR COUNSEL, Reminds DouYu International Holdings Limited Investors of Important Deadline in First Filed Federal Securities Class Action Lawsuit – DOYU NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of DouYu International Holdings Limited (NASDAQ: DOYU) pursuant and/or traceable to DouYu’s July 16, 2019 initial public offering (the “IPO” or the “Offering”) of the impo
March 28, 2020 20:47 UTC
Games Industry Unites to Promote World Health Organization Messages Against COVID-19; Launch #PlayApartTogether Campaign
Games Industry Unites to Promote World Health Organization Messages Against COVID-19; Launch #PlayApartTogether Campaign March 28, 2020 20:47 UTC Games Industry Unites to Promote World Health Organization Messages Against COVID-19; Launch #PlayApartTogether Campaign Global Games Industry Encourages Players to Follow Health and Safety Guidelines for COVID-19; Provides Information and Social Connection --(BUSINESS WIRE)-- Zynga (NASDAQ:ZNGA): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200328005018/en/Games Industry Unites to Promote World Health Organization Messages Against COVID-19; Launch #PlayApartTogether Camp
March 28, 2020 20:15 UTC
Bloom Energy, State of California, Almo Partner to Refurbish Ventilators for Healthcare System as COVID-19 Spreads Throughout U.S.
Bloom Energy, State of California, Almo Partner to Refurbish Ventilators for Healthcare System as COVID-19 Spreads Throughout U.S. March 28, 2020 20:15 UTC Bloom Energy, State of California, Almo Partner to Refurbish Ventilators for Healthcare System as COVID-19 Spreads Throughout U.S. Companies leverage expertise to breathe new life into machines in fight against coronavirus SAN JOSE, Calif. & PHILADELPHIA--(BUSINESS WIRE)-- Bloom Energy Corp. (NYSE: BE) and Almo Corporation today announced they are joining forces to refurbish unused, out-of-warranty ventilators and ship them to state agencies and hospitals throughout the country, particularly as an increasing number of patient
March 28, 2020 18:30 UTC
CORRECTING and REPLACING Stratasys Coalition for Face Shield Production With 3D Printing Now Numbers Over 150 Organizations Responding to Pandemic
CORRECTING and REPLACING Stratasys Coalition for Face Shield Production With 3D Printing Now Numbers Over 150 Organizations Responding to Pandemic March 28, 2020 18:30 UTC CORRECTING and REPLACING Stratasys Coalition for Face Shield Production With 3D Printing Now Numbers Over 150 Organizations Responding to Pandemic Requests from hospitals and other organizations exceed 350,000 shields; first hospital shipment received on Mar. 25 CORRECTION…by Stratasys Ltd.EDEN PRAIRIE, Minn. & REHOVOT, Israel--(BUSINESS WIRE)-- First paragraph, second sentence of release dated March 27, 2020 should include General Atomics sted Toyota Motor Company. This press release features multimed
March 28, 2020 14:00 UTC
Investigational Drug Vericiguat Significantly Reduced the Risk of the Composite Endpoint of Heart Failure Hospitalization or Cardiovascular Death, Compared to Placebo, When Given in Combination with Available Heart Failure Therapies
Investigational Drug Vericiguat Significantly Reduced the Risk of the Composite Endpoint of Heart Failure Hospitalization or Cardiovascular Death, Compared to Placebo, When Given in Combination with Available Heart Failure Therapies March 28, 2020 14:00 UTC Investigational Drug Vericiguat Significantly Reduced the Risk of the Composite Endpoint of Heart Failure Hospitalization or Cardiovascular Death, Compared to Placebo, When Given in Combination with Available Heart Failure Therapies Phase 3 VICTORIA Trial is the First Contemporary Outcomes Study Focused Exclusively on a Chronic Heart Failure Patient Population Following a Worsening Event KENILWORTH, N.J.--(BUSINESS WIRE)-- Me
March 28, 2020 13:53 UTC
FARXIGA reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial
FARXIGA reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial March 28, 2020 13:53 UTC FARXIGA reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial New data showed consistent effect of FARXIGA in patients with heart failure with reduced ejection fraction, regardless of background therapy WILMINGTON, Del.--(BUSINESS WIRE)-- New data from a sub-analysis of the landmark Phase III DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure) trial showed that AstraZeneca’s FARXIGA (dapagliflozin) reduced the incidence

Execution time: 0.3769 seconds
Layout: desktop